BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1589587)

  • 1. Nortriptyline response in elderly depressed patients.
    Kanba S; Matsumoto K; Nibuya M; Suzuki E; Kinoshita N; Shintani F; Yagi G
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 May; 16(3):301-9. PubMed ID: 1589587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma 10-hydroxynortriptyline in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Manley MW; Dhar AK; Kutt H
    Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study.
    Kin NM; Klitgaard N; Nair NP; Amin M; Kragh-Sorensen P; Schwariz G; Ahmed SK; Holm P; Katona C; Stage K
    Neuropsychopharmacology; 1996 Jul; 15(1):1-6. PubMed ID: 8797186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.
    Nordin C; Bertilsson L; Dahl ML; Resul B; Toresson G; Sjöqvist F
    Psychopharmacology (Berl); 1991; 103(3):287-90. PubMed ID: 2057534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10-Hydroxynortriptyline and treatment effects in elderly depressed patients.
    McCue RE; Georgotas A; Suckow RF; Cooper TB
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):176-80. PubMed ID: 2521060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isomers of 10-hydroxynortriptyline in geriatric depression.
    Young RC; Dhar AK; Kutt H; Alexopoulos GS
    Ther Drug Monit; 1988; 10(2):164-7. PubMed ID: 3381232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.
    Schneider LS; Cooper TB; Severson JA; Zemplenyi T; Sloane RB
    J Clin Psychopharmacol; 1988 Dec; 8(6):402-8. PubMed ID: 3069881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Zerbi F; Savoldi F
    Psychopharmacology (Berl); 1990; 100(3):334-8. PubMed ID: 2315430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline.
    Young RC; Mattis S; Alexopoulos GS; Meyers BS; Shindledecker RD; Dhar AK
    Psychopharmacol Bull; 1991; 27(3):291-4. PubMed ID: 1775601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Kent E; Dhar AK; Kutt H
    Am J Psychiatry; 1985 Jul; 142(7):866-8. PubMed ID: 4014510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
    Monteleone P; Fabrazzo M
    Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
    Nordin C; Bertilsson L; Siwers B
    Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed.
    McCue RE; Georgotas A; Nagachandran N; Abdul Basir M; Go EA; Suckow RF; Cooper TB
    J Psychiatr Res; 1989; 23(1):73-9. PubMed ID: 2754630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
    Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
    J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
    Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
    J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nortriptyline in the hospitalized elderly: tolerance and side effect reduction.
    Rosen J; Sweet R; Pollock BG; Mulsant BH
    Psychopharmacol Bull; 1993; 29(2):327-31. PubMed ID: 8290682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal analysis of nortriptyline side effects in elderly depressed patients.
    Miller MD; Pollock BG; Rifai AH; Paradis CF; Perel JM; George C; Stack JA; Reynolds CF
    J Geriatr Psychiatry Neurol; 1991; 4(4):226-30. PubMed ID: 1789911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amitriptyline metabolism in relation to antidepressive effect.
    Edelbroek PM; Zitman FG; Schreuder JN; Rooymans HG; de Wolff FA
    Clin Pharmacol Ther; 1984 Apr; 35(4):467-73. PubMed ID: 6705444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma 10-hydroxynortriptyline and therapeutic response in geriatric depression.
    Young RC; Alexopoulos GS; Shindledecker R; Dhar AK; Kutt H
    Neuropsychopharmacology; 1988 Sep; 1(3):213-5. PubMed ID: 3251501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.
    Burch JE
    Psychopharmacology (Berl); 1983; 80(3):254-8. PubMed ID: 6412270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.